Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15007267Phase 4Completed
Phase 4, randomised, double-blind trial of celecoxib in knee osteoarthritis (OA) (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Started Nov 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15007267.